Moxiclav (Amoxicillin, Clavulanic Acid)

Amoxicillin disrupts bacterial cell wall synthesis by binding to penicillin‑binding proteins, causing cell lysis. Clavulanic acid blocks beta‑lactamase enzymes that many bacteria produce, protecting amoxicillin from degradation and extending its antimicrobial coverage.

The dosage of Moxiclav is determined by the prescribing clinician based on the infection type, severity, patient age, weight, and renal function. Only a qualified healthcare professional should set the appropriate regimen.

Safety data for Moxiclav in pregnancy are limited, and it should only be used when the potential benefit justifies any risk to the fetus. Breastfeeding mothers should consult a healthcare provider, as the drug can be excreted in milk.

To order Moxiclav, submit an enquiry on the product page at gnhindia.com, specifying the required quantity. GNH India works with hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details and any necessary import documentation.

Moxiclav offers a broader spectrum than amoxicillin alone because clavulanic acid inhibits beta‑lactamases. Compared with other beta‑lactam/beta‑lactamase inhibitor combos, it provides similar efficacy but may differ in dosing frequency, tolerability and specific bacterial coverage.

Moxiclav tablets or oral suspension should be stored at ambient temperature, preferably below 25 °C. Keep the product in its original container, protect it from moisture, and discard any material that appears discoloured or expired.

Moxiclav is taken orally, usually with food to reduce gastrointestinal upset. The tablet or liquid should be swallowed whole (or measured accurately for liquid forms) as directed by the prescriber.

Serious risks include severe allergic reactions such as anaphylaxis, life‑threatening skin conditions like Stevens‑Johnson syndrome, Clostridioides difficile‑associated colitis, and significant liver enzyme elevations that may indicate hepatic injury.

Patients with a known hypersensitivity to amoxicillin, other penicillins, or clavulanic acid should avoid Moxiclav. It is also contraindicated in individuals with a history of severe beta‑lactamase inhibitor reactions or those who have experienced serious liver toxicity from similar agents.